Gut bacteria-derived 3-phenylpropionylglycine mitigates adipocyte differentiation of 3T3-L1 cells by inhibiting adiponectin-PPAR pathway.
Saved in:
| Title: | Gut bacteria-derived 3-phenylpropionylglycine mitigates adipocyte differentiation of 3T3-L1 cells by inhibiting adiponectin-PPAR pathway. |
|---|---|
| Authors: | Jung HR; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea., Oh Y; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea., Jang D; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea., Shin S; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea., Lee SJ; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea., Kim J; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea., Lee SE; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea., Oh J; Department of Translational Medicine, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea., Jang G; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea., Kwon O; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea., Lee Y; Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, 21999, Republic of Korea., Lee HY; Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, 21999, Republic of Korea.; Division of Molecular Medicine, Department of Medicine, Gachon University College of Medicine, Incheon, 21565, Republic of Korea., Cho SY; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea. csybio@snu.ac.kr.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea. csybio@snu.ac.kr.; Department of Translational Medicine, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea. csybio@snu.ac.kr.; Cancer Research Institute, Seoul National University, Seoul, 03080, Republic of Korea. csybio@snu.ac.kr. |
| Source: | Genes & genomics [Genes Genomics] 2023 Jan; Vol. 45 (1), pp. 71-81. Date of Electronic Publication: 2022 Nov 24. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: The Korean Society of Genetics Country of Publication: Korea (South) NLM ID: 101481027 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2092-9293 (Electronic) Linking ISSN: 19769571 NLM ISO Abbreviation: Genes Genomics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2092-9293 |
|---|---|
| DOI: | 10.1007/s13258-022-01332-y |
